Get the Stockscreener App
1.02
2.86%
-0.03
Biovie Inc stock is traded at $1.02, with a volume of 143.44K.
It is down -2.86% in the last 24 hours and down -42.37% over the past month.
BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The Company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.
See More
Previous Close:
$1.05
Open:
$1.06
24h Volume:
143.44K
Relative Volume:
0.18
Market Cap:
$18.82M
Revenue:
-
Net Income/Loss:
$-25.56M
P/E Ratio:
-0.1962
EPS:
-5.2
Net Cash Flow:
$-19.35M
1W Performance:
-15.00%
1M Performance:
-42.37%
6M Performance:
-67.72%
1Y Performance:
-85.60%
1-Day Range:
$0.985
$1.08
1-Week Range:
$0.985
$1.205
52-Week Range:
$0.985
$7.50
Biovie Inc Stock (BIVI) Company Profile
Name
Biovie Inc
Sector
Industry
Phone
775-888-3162
Address
680 W NYE LANE, CARSON CITY
Compare BIVI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BIVI
Biovie Inc
|
1.02 | 18.82M | 0 | -25.56M | -19.35M | -5.20 |
|
VRTX
Vertex Pharmaceuticals Inc
|
502.92 | 129.14B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
680.61 | 74.41B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
581.21 | 35.31B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
241.75 | 31.30B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
254.57 | 27.35B | 3.32B | -860.46M | -1.04B | -8.32 |
Biovie Inc Stock (BIVI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-22-22 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-15-21 | Initiated | B. Riley Securities | Buy |
Biovie Inc Stock (BIVI) Latest News
Biovie stock plunges to 52-week low, touches $1.04 - Investing.com India
Biovie stock plunges to 52-week low, touches $1.04 By Investing.com - Investing.com South Africa
New to The Street Show 633 to Broadcast on Fox Business Network as Sponsored Programming Tonight at 10:30 PM PST Featuring Zapp Electric Vehicles ($ZAPP), BioVie ($BIVI), PetVivo ($PETV), and Banzai ($BNZI) - Galveston County Daily News
BIVI 2-WEEK DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages BioVie (BIVI) Investors with Substantial Losses to Contact its Attorneys Before Mar. 19th Deadline in Securities Fraud Class Action Over Failed Phase 3 Clinical Trial - ACCESS Newswire
BioVie Inc. (NASDAQ:BIVI) Short Interest Up 21.8% in February - Defense World
New to the Street Airs Show #630 on Fox Business Network Tonight at 10:30 PM PST Featuring Roadzen ($RDZN), BioVie ($BIVI), AtlasClear (ATCH), eXoZymes ($EXOZ), and EvolveHealthandLifestyle. - Markets Insider
New to the Street Airs Show #630 on Fox Business Network Tonight at 10:30 PM PST Featuring Roadzen ($RDZN), BioVie ($BIVI), AtlasClear (ATCH), eXoZymes ($EXOZ), and EvolveHealthandLifestyle.com With Craig Bruce - Corsicana Daily Sun
New to the Street Airs Show #630 on Fox Business Network Tonight at 10:30 PM PST Featuring Roadzen ($RDZN), BioVie ($BIVI), AtlasClear (ATCH), eXoZymes ($EXOZ), and EvolveHealthandLifestyle.com With C - StreetInsider.com
BioVie Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More InformationBIVI - ACCESS Newswire
SHAREHOLDER ALERT: Levi & Korsinsky Notifies BioVie Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineBIVI - ACCESS Newswire
IMMINENT BIVI DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds BioVie Inc. Investors to Join the Class Action Lawsuit! - ACCESS Newswire
BIVI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Reminds BioVie Inc. Investors to Join the Class Action Lawsuit! - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Encourages BioVie Inc. (BIVI) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
SHAREHOLDER ALERT: Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 19, 2024 in BioVie LawsuitBIVI - ACCESS Newswire
BIVI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that BioVie Inc. Investors Can Join the Class Action Lawsuit! - ACCESS Newswire
Shareholders that lost money on BioVie Inc. (BIVI) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
Shareholders that lost money on BioVie Inc.(BIVI) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
BioVie Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationBIVI - ACCESS Newswire
BioVie Inc. and iRemedy Interviews to Air on Bloomberg U.S. on the RedChip Money Report(R) - ACCESS Newswire
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of BioVie Inc.(BIVI) Shareholders - ACCESS Newswire
UPCOMING BIVI DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds BioVie Inc. Investors to Join the Class Action Lawsuit! - ACCESS Newswire
New to The Street to Broadcast Live on Bloomberg Tonight at 6:30 PM EST as Sponsored Programming, Spotlighting BioVie (BIVI), RoadZen (RDZN), HPB, and Sustainable Innovation With Shark Tank’s Kevin Harrington and Sustainable Green Team (SGTM) - The Hastings Tribune
New to The Street to Broadcast Live on Bloomberg Tonight at 6:30 PM EST as Sponsored Programming, Spotlighting BioVie (BIVI), RoadZen (RDZN), HPB, and Sustainable Innovation With Shark Tank's Kevin Harrington and Sustainable Green Team (SGTM) - Big News Network
BIVI LAWSUIT ALERT: Levi & Korsinsky Notifies BioVie Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ACCESS Newswire
INVESTOR ALERT: Levi & Korsinsky Notifies Shareholders of BioVie Inc. (BIVI) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire
Is BioVie (NASDAQ:BIVI) In A Good Position To Invest In Growth? - Yahoo Finance
BioVie Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm - ACCESS Newswire
A Guide To The Risks Of Investing In BioVie Inc (BIVI) - Knox Daily
BioVie Inc (NASDAQ: BIVI): How Can A Stock Be Down -4.00% Year To Date, But Still Loser - Marketing Sentinel
Healthy Upside Potential: BioVie Inc (BIVI) - SETE News
Now Is The Time To Build A Position In BioVie Inc (NASDAQ:BIVI) - Marketing Sentinel
BioVie Inc (BIVI) Stock: Navigating Drops and Gains - The InvestChronicle
BioVie Inc (BIVI)’s stock rises to 1.74 per share - US Post News
Stock Market Recap: BioVie Inc (BIVI) Concludes at 1.60, a -3.03 Surge/Decline - The Dwinnex
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against BioVie Inc. (BIVI) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
2025-01-26 | Bronstein, Gewirtz & Grossman, LLC Encourages BioVie Inc. (BIVI) Shareholders to Inquire about Securities Investigation | NDAQ:BIVI | Press Release - Stockhouse Publishing
BioVie Inc. ($BIVI) Joins Forces With New to The Street for a Dynamic 6-Part Media Campaign Featuring Long-Form Interviews, National TV Commercials, Iconic Billboards, and Exclusive Accredited Events - ACCESS Newswire
BioVie and Genetic Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - ACCESS Newswire
2025-01-19 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against BioVie Inc. (BIVI) And Encourages Shareholders to Reach Out | NDAQ:BIVI | Press Release - Stockhouse Publishing
2025-01-15 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against BioVie Inc. (BIVI) and Encourages Shareholders to Learn More About the Investigation | NDAQ:BIVI | Press Release - Stockhouse Publishing
2025-01-12 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against BioVie Inc. (BIVI) and Encourages Investors to Learn More About the Investigation | NDAQ:BIVI | Press Release - Stockhouse Publishing
BioVie Inc. (BIVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - AccessWire
Bronstein, Gewirtz & Grossman, LLC Is Investigating BioVie Inc. (BIVI) And Encourages Investors to Connect - Stockhouse Publishing
BIOVIE ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
BIOVIE, INC. CLASS ACTION ALERT: Biovie, Inc. Class Action Alert: Wolf Haldenstein Adler Freeman & Herz LLP Announces That a Class Action Lawsuit Has Been Filed In The United States District Court for The District of Nevada Against Biovie, Inc. - AccessWire
2025-01-02 | Bronstein, Gewirtz & Grossman, LLC Encourages BioVie Inc. (BIVI) Stockholders to Inquire about Securities Investigation | NDAQ:BIVI | Press Release - Stockhouse Publishing
BioVie Leaders Sued for Stock Slips on Clinical Trial Misconduct - Bloomberg Law
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against BioVie Inc. (BIVI) And Encourages Investors to Reach Out - AccessWire
Certain Common Stock of BioVie Inc. are subject to a Lock-Up Agreement Ending on 24-DEC-2024. - Marketscreener.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against BioVie Inc. (BIVI) And Encourages Stockholders to Reach Out - AccessWire
Bronstein, Gewirtz & Grossman, LLC Is Investigating BioVie Inc. (BIVI) And Encourages Stockholders to Connect - AccessWire
Biovie Inc Stock (BIVI) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.39%
0.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):